371
Views
1
CrossRef citations to date
0
Altmetric
Research Reports

Deep clinical phenotyping and gene expression analysis in a patient with RCBTB1-associated retinopathy

, , , , ORCID Icon, ORCID Icon, , , , , , , , , & ORCID Icon show all
Pages 266-275 | Received 24 Aug 2020, Accepted 07 Feb 2021, Published online: 24 Feb 2021

References

  • Wu J-H, Liu J-H, Ko Y-C, Wang C-T, Chung Y-C, Chu K-C, Liu -T-T, Chao H-M, Jiang Y-J, Chen S-J, et al. Haploinsufficiency of RCBTB1 is associated with Coats disease and familial exudative vitreoretinopathy. Hum Mol Genet. 2016;25(8):1637–47. doi:10.1093/hmg/ddw041.
  • Coppieters F, Ascari G, Dannhausen K, Nikopoulos K, Peelman F, Karlstetter M, Xu M, Brachet C, Meunier I, Tsilimbaris M, et al. Isolated and syndromic retinal dystrophy caused by biallelic mutations in RCBTB1, a gene implicated in ubiquitination. Am J Hum Genet. 2016;99(2):470–80. doi:10.1016/j.ajhg.2016.06.017.
  • Huang Z, Zhang D, Chen S-C, Thompson JA, McLaren T, Lamey T, De Roach JN, McLenachan S, Chen FK. Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations. Stem Cell Res. 2019;40:101549.
  • Bennett RL, Steinhaus KA, Uhrich SB, O’Sullivan CK, Resta RG, Lochner-Doyle D, Markel DS, Vincent V, Hamanishi J. Recommendations for standardized human pedigree nomenclature. Pedigree standardization task force of the national society of genetic counselors. Am J Hum Genet 1995;56:745–52.
  • Bennett RL, French KS, Resta RG, Doyle DL.Standardized human pedigree nomenclature: update and assessment of the recommendations of the national society of genetic counselors. J Genet Couns. 2008;17(5):424–33. doi:10.1007/s10897-008-9169-9.
  • McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1–12. doi:10.1007/s10633-014-9473-7.
  • Constable PA, Bach M, Frishman LJ, Jeffrey BG, Robson AG.International society for clinical electrophysiology of V. ISCEV standard for clinical electro-oculography (2017 update). Doc Ophthalmol. 2017;134(1):1–9. doi:10.1007/s10633-017-9573-2.
  • Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, Meigen T, Viswanathan S. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2013;126(1):1–7. doi:10.1007/s10633-012-9353-y.
  • Schwarz JM, Rodelsperger C, Schuelke M, Seelow D.MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–76. doi:10.1038/nmeth0810-575.
  • Hu J, Ng PC, Toland A.SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins. PLoS One. 2013;8(10):e77940. doi:10.1371/journal.pone.0077940.
  • Douville C, Masica DL, Stenson PD, Cooper DN, Gygax DM, Kim R, Ryan M, Karchin R. Assessing the pathogenicity of insertion and deletion variants with the variant effect scoring tool (VEST-indel). Hum Mutat. 2016;37(1):28–35. doi:10.1002/humu.22911.
  • Sergouniotis PI, Barton SJ, Waller S, Perveen R, Ellingford JM, Campbell C, Hall G, Gillespie RL, Bhaskar SS, Ramsden SC, et al. The role of small in-frame insertions/deletions in inherited eye disorders and how structural modelling can help estimate their pathogenicity. Orphanet J Rare Dis. 2016;11(1):125. doi:10.1186/s13023-016-0505-0.
  • Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7(1):539. doi:10.1038/msb.2011.75.
  • Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ.The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10(6):845–58. doi:10.1038/nprot.2015.053.
  • Janson G, Zhang C, Prado MG, Paiardini A.PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOL. Bioinformatics. 2017;33(3):444–46. doi:10.1093/bioinformatics/btw638.
  • Keenan TD, Agrón E, Domalpally A, Clemons TE, Van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. (1549-4713 (Electronic)).
  • Batıoğlu F, Gedik Oğuz YF, Demirel S, Ozmert E. Geographic atrophy progression in eyes with age-related macular degeneration: role of fundus autofluorescence patterns, fellow eye and baseline atrophy area. (1423-0259 (Electronic)).
  • Cicinelli MA-O, Battista M, Starace VA-O, Battaglia Parodi M, Bandello FA-O Monitoring and management of the patient with stargardt disease. (1179-2752 (Electronic)).
  • McBain VA, Townend JF, Lois N. Progression of retinal pigment epithelial atrophy in stargardt disease. (1879-1891 (Electronic)).
  • Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Cideciyan AV, Audo I, Birch DG, Hariri AH, Nittala MG, et al. Progression of stargardt disease as determined by fundus autofluorescence in the retrospective progression of stargardt disease study (ProgStar report no. 9). JAMA Ophthalmol. 2017;135(11):1232–41. doi:10.1001/jamaophthalmol.2017.4152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.